Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Assessing mean apnea-hypopnea duration (MAD) in patients with OSA yields hypoxemia and symptom burden data not provided by the AHI or ODI.

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...

Untreated sleep apnea can affect heart health, diabetes, cognitive function, and more.

TORONTO, ONTARIO, CANADA - 2014/04/12: Female wearing the CPAP mask for treating the sleep apnea which is a type of sleep disorder characterized by pauses in breathing or instances of shallow or ...

Patients with obstructive sleep apnea appear to be at greater risk for kidney and bladder cancer. Obstructive sleep apnea is associated with a higher risk for kidney and bladder cancer, but not ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

The global sleep apnea implants market is projected to expand at a compound annual growth rate (CAGR) of approximately 10% ...